Loading results ...
 

Blog Posts

New Technologies Advancing Translational Research and Biomarker Development

In today’s era of personalized medicine, new advancements in biospecimen management, science and technology are enabling researchers to introduce innovative medical therapies to the market. Technology continues to be a key driver that is impacting how biological samples are being used to make more specific and sensitive measurements of molecular biomarkers. The discovery of biomarkers […]

Read more »

BioStorage Firmly Behind the Scenes of Personalized Medicine

Personalized medicine, the precise targeting of specific drugs to treat specific patients based on the genetic details of their disease, is quickly becoming a reality. In fact, the precipitous decline in the cost of sequencing patients’ specimens is leading to a flood of genetic information that is being exploited to diagnose and treat patients. An […]

Read more »

Top Trends in R&D Outsourcing Impacting Future R&D Success

The biopharmaceutical industry faces a unique challenge in its quest to develop new and innovative therapies. Unlike any other industry, Biopharma research is dependent upon the human body and its genome. In a sense, it is working to drive continual innovation within a highly complex, but closed environment. Not surprisingly, Biopharma is finding it more […]

Read more »

Is Your Biorepository a Certified Cargo Screening Facility?

Due to the substantial requirements of the 9/11 Act, pre-inspection of research samples at a Certified Cargo Screening Facility can eliminate bottlenecks in the air cargo supply chain and reduce the risk of transportation damage to precious cargo, saving you time and money. In July of 2010, BioStorage Technologies was approved as a Certified Cargo […]

Read more »

Join BioStorage Technologies at ISBER for Workshops, Poster Presentations, Interactive Discussions and a Fireworks Party!

The International Society for Biological and Environmental Repositories (ISBER) is a global biobanking community that supports the largest international forum for technical, legal, ethical and managerial issues relevant to repositories of biological and environmental specimens worldwide. The ISBER 2014 Annual Meeting takes place May 20-24 at Walt Disney World in Orlando, FL. This meeting will […]

Read more »

The Role of Technology in Advancing Pharmaceutical Drug Discovery and Development

Embracing Innovative Technologies The drug development industry is entering a new technology era that is filled with both opportunities and challenges. Due to an increasing array of cost-reduction, efficiency objectives and safety drivers from the commercial, regulatory and patient sectors –the likes of which have never been seen before – research organizations are embracing innovative […]

Read more »

Collaborative Partnerships that Optimize & Accelerate Pharmaceutical Drug Development

Smartsourcing = Value by Innovation It has been widely recognized that the global pharmaceutical industry is experiencing dynamic change. Under high pressure to contain fixed costs, many biopharmaceutical companies have reduced their internal staff and infrastructure capacities in drug R&D, manufacturing and other supporting functions, instead opting to outsource these functions. With the growing sophistication […]

Read more »

Biobanking Informatics: Transforming Biological Samples into Scientific & Financial Assets

Today, advancements in medical therapies rely heavily on a researcher’s ability to manage sample assets and to efficiently link clinical and laboratory data to collected samples. As a result, the need for a full-scale, computerized database that stores, organizes, indexes and analyzes samples and their associated data has become a critical component in the drug […]

Read more »

Sample Management Challenges and Opportunities in Asia Pacific

The Asia-Pacific region is home to over three billion people. With a combined total economy estimated at $20 trillion, five countries in the region -China, Japan, India, Australia and Korea- rank among the Top 15 largest economies in the world. As global biopharmaceutical companies continue to expand clinical trial research in Asia-Pacific, the need for […]

Read more »

Long-term Business Growth in China Depends on Collaboration

Conducting clinical trial research in China has become a top global strategic priority for many biopharmaceutical executives. Even though language and cultural barriers remain, transportation infrastructure is limited and the expectation for governmental scrutiny has increased, China is considered one of the world’s most attractive drug development markets, and the fastest-growing. Since 2006, 13 of […]

Read more »